Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EIDX

Eidos Therapeutics (EIDX) Stock Price, News & Analysis

Eidos Therapeutics logo

About Eidos Therapeutics Stock (NASDAQ:EIDX)

Advanced Chart

Key Stats

Today's Range
$122.21
$122.21
50-Day Range
$120.98
$128.51
52-Week Range
$28.39
$132.54
Volume
N/A
Average Volume
128,113 shs
Market Capitalization
$4.75 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EIDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eidos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EIDX Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
The Anglo File: Game Over for Board Lapses at Eidos
See More Headlines

EIDX Stock Analysis - Frequently Asked Questions

Eidos Therapeutics, Inc. (NASDAQ:EIDX) posted its quarterly earnings results on Thursday, October, 29th. The company reported ($0.79) earnings per share for the quarter, missing analysts' consensus estimates of ($0.71) by $0.08. The company had revenue of $0.13 million for the quarter.

Eidos Therapeutics (EIDX) raised $101 million in an initial public offering (IPO) on Wednesday, June 20th 2018. The company issued 6,300,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and Barclays was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eidos Therapeutics investors own include Bristol Myers Squibb (BMY), CRISPR Therapeutics (CRSP), Exelixis (EXEL), NVIDIA (NVDA), Micron Technology (MU), Axsome Therapeutics (AXSM) and Occidental Petroleum (OXY).

Company Calendar

Last Earnings
10/29/2020
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EIDX
CIK
N/A
Fax
N/A
Employees
70
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$37.83 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$26.69 million
Price / Cash Flow
N/A
Book Value
$4.57 per share
Price / Book
26.74

Miscellaneous

Free Float
N/A
Market Cap
$4.75 billion
Optionable
Not Optionable
Beta
-0.16
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:EIDX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners